联系客服

300404 深市 博济医药


首页 公告 博济医药:2023年半年度非经营性资金占用及其他关联资金往来情况汇总表

博济医药:2023年半年度非经营性资金占用及其他关联资金往来情况汇总表

公告日期:2023-08-26

博济医药:2023年半年度非经营性资金占用及其他关联资金往来情况汇总表 PDF查看PDF原文

                              博济医药科技股份有限公司

                2023 年半年度非经营性资金占用及其他关联资金往来情况汇总表

  编制单位:博济医药科技股份有限公司                                                                      单位:元

                              占用方与上市 上市公司核 2023 年期初2023 年半年度 2023 年半年 2023 年半年 2023 年上半

 非经营性资金  资金占用方名称  公司的关联关 算的会计科 占用资金余 占用累计发生度占用资金的 度偿还累计 年末占用资 占用形  占用性质
    占用                          系        目        额    金额(不含利利息(如有) 发生金额    金余额  成原因

                                                                    息)

控股股东、实际
 控制人及其附

  属企业

    小计            -              -          -                                                                              -

前控股股东、实
 际控制人及其

  附属企业

    小计            -              -          -                                                                              -

 其他关联方及

  附属企业

    小计

    总计            -              -          -                                                                              -


                              往来方与上市 上市公司核 2023 年期初2023 年半年度 2023 年半年 2023 年半年 2023 年上半          往来性质

其它关联资金  资金往来方名称  公司的关联关 算的会计科 往来资金余 往来累计发生度往来资金的 度偿还累计 年期末往来 往来形 (经营性往来、
    往来                          系        目        额    金额(不含利利息(如有) 发生金额  资金余额  成原因 非经营性往来)
                                                                    息)

              广州华圣细胞科技有 实际控制人王                                                                          办公室租

                    限公司      廷春的儿子控  应收账款        -          8,812.80          -          8,812.80          -        赁    经营性往来
                                  制的企业

控股股东、实际 广州博峰微球科技有 实际控制人王

 控制人及其附      限公司      廷春的儿子控  合同资产    120,000.00    170,000.00          -        120,000.00    170,000.00  提供服务  经营性往来
  属企业                        制的企业

              广州博峰微球科技有 实际控制人王                                                                          办公室租

                    限公司      廷春的儿子控  应收账款    460,000.00    736,000.00          -        721,000.00    475,000.00  赁、提供  经营性往来
                                  制的企业                                                                              服务

              上海砝码斯医药生物 全资子公司  其他应收款                                                                往来款  非经营性往来
                科技有限公司                                7,070,000.00    3,300,000.00        -            -        10,370,000.00

              重庆博济医药科技有 控股子公司  其他应收款                                                                往来款  非经营性往来
                    限公司                                    1,500,000.00        -              -            -        1,500,000.00

 上市公司的子 深圳博瑞医药科技有 全资子公司  其他应收款                                                                往来款  非经营性往来
                    限公司                                    32,959,900. 00        -              -            -        32,959,900.00

 公司及其附属 广州博济生物医药科

    企业        技园有限公司    控股子公司  其他应收款      -        8,000,000.00        -            -        8,000,000.00  往来款  非经营性往来

              西藏博济投资管理有 全资子公司  其他应收款                                                                往来款  非经营性往来
                    限公司                                        -        3,300,000.00        -            -        3,300,000.00

              广州博济多肽科技有 控股子公司  其他应收款                                                                往来款  非经营性往来
                    限公司                                        -        200,000.00          -            -        200,000.00


              广州博济新药临床研 全资子公司  其他应收款                                                                往来款  非经营性往来
                究中心有限公司                                    -        134,738.26          -        134,738.26        -

其他关联方及
 其附属企业

  总计            -              -          -      42,109,900.00  15,849,551.06        -        984,551.06  56,974,900.00    -        -

  法定代表人:王廷春                                  主管会计工作负责人:欧秀清                              会计机构负责人:陈展鹏
[点击查看PDF原文]